Home    中文  
 
  • Search
  • lucene Search
  • Citation
  • Fig/Tab
  • Adv Search
Just Accepted  |  Current Issue  |  Archive  |  Featured Articles  |  Most Read  |  Most Download  |  Most Cited

Chinese Journal of Breast Disease(Electronic Edition) ›› 2007, Vol. 01 ›› Issue (05): 153-154. doi: 10.3877/cma.j.issn.1674-0807.2007.05.009

Special Issue:

• Clinical Research • Previous Articles     Next Articles

Mucinous carcinoma of the breast:report of 58 cases

Wei HU1, Jun-yi SHI,1(), Yuan SHENG1, Li LI1   

  1. 1.Department of General Surgery,Changhai Hospital,Second Military Medical University,Shanghai 200433,China
  • Received:2007-04-16 Online:2007-10-01 Published:2024-12-12
  • Contact: Jun-yi SHI

Abstract:

Objective

To explore the clinical features, prognosis and breast-conserving therapy of mucinous carcinoma of the breast (MCB).

Methods

Fifty-eight cases of MCB were divided into two groups:pure type ( n =35) and mixed type ( n =23).Fifty patients were treated by breast-conserving surgery, the others were treated by modified radical mastectomy.The clinical features, treatment measures and follow-up results were analyzed.

Results

In female patients with median age of 47 years, 70.69% were premenopause.The tumor size ranged from 1 cm to 15 cm.None of the pure MCB patients demonstrated lymph node metastases, whereas 65.22% of mixed MCB patients did.The 5-year survival rate of MCB was 89.66% (pure type 97.14% , mixed type 78.26% ).

Conclusions

MCB should be carefully examined in 35-50-year-old premenopausal women with tumor which seems benign on the surface and accurate diagnosis is made before lumpectomy.The prognosis of MCB is much better and the preferred method of treatment for MCB is conservative surgical therapy.The result shows pure MCB unlikely metastasize, axillary lymph node dissection may be unnecessary in the treatment of pure MCB.

Key words: Mucinous carcinoma, Axillary node metastases, Breast-conserving therapy

京ICP 备07035254号-13
Copyright © Chinese Journal of Breast Disease(Electronic Edition), All Rights Reserved.
Tel: 0086-10-51322630 E-mail: jcbd@medmail.com.cn
Powered by Beijing Magtech Co. Ltd